Format

Send to

Choose Destination
Acta Neuropathol. 2019 Aug 20. doi: 10.1007/s00401-019-02044-6. [Epub ahead of print]

Correction to: An update on the CNS manifestations of neurofibromatosis type 2.

Coy S1,2,3, Rashid R1,3,4, Stemmer-Rachamimov A3,5, Santagata S6,7,8,9,10.

Author information

1
Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Hale Building for Transformative Medicine, BTM8002P, 60 Fenwood Road, Boston, MA, 02115, USA.
2
Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
3
Harvard Medical School, Boston, MA, USA.
4
Laboratory for Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA.
5
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
6
Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Hale Building for Transformative Medicine, BTM8002P, 60 Fenwood Road, Boston, MA, 02115, USA. ssantagata@bics.bwh.harvard.edu.
7
Department of Pathology, Boston Children's Hospital, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
8
Harvard Medical School, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
9
Laboratory for Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.
10
Ludwig Center at Harvard, Boston, MA, USA. ssantagata@bics.bwh.harvard.edu.

Abstract

The article An update on the CNS manifestations of neurofibromatosis type 2, written by Shannon Coy, Rumana Rashid, Anat Stemmer‑Rachamimov and Sandro Santagata, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 04 June 2019 without open access.

PMID:
31432207
DOI:
10.1007/s00401-019-02044-6

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center